Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

Irina A. Tikhonova (), Tracey Jones-Hughes, James Dunham, Fiona C. Warren, Sophie Robinson, Peter Stephens and Martin Hoyle
Additional contact information
Irina A. Tikhonova: Peninsula Technology Assessment Group (PenTAG)
Tracey Jones-Hughes: Peninsula Technology Assessment Group (PenTAG)
James Dunham: Peninsula Technology Assessment Group (PenTAG)
Fiona C. Warren: Peninsula Technology Assessment Group (PenTAG)
Sophie Robinson: Peninsula Technology Assessment Group (PenTAG)
Peter Stephens: Royal Devon and Exeter NHS Foundation Trust
Martin Hoyle: Peninsula Technology Assessment Group (PenTAG)

PharmacoEconomics, 2018, vol. 36, issue 4, No 12, 507-507

Abstract: Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-018-0635-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-018-0635-4

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-018-0635-4

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().